Cargando…

What happened to microbiological diagnosis in 2020 beyond COVID-19?

The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications rel...

Descripción completa

Detalles Bibliográficos
Autor principal: Cercenado, Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683012/
https://www.ncbi.nlm.nih.gov/pubmed/34598413
http://dx.doi.org/10.37201/req/s01.01.2021
_version_ 1784617326557003776
author Cercenado, Emilia
author_facet Cercenado, Emilia
author_sort Cercenado, Emilia
collection PubMed
description The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications related to new diagnostic tests, methods for rapid antimicrobial susceptibility testing and for the detection of resistance genes, new diagnostic technologies, and some aspects related to old and emergent pathogens (Candida auris, Elizabethkingia spp. Streptococcus pyogenes) are summarized.
format Online
Article
Text
id pubmed-8683012
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-86830122021-12-29 What happened to microbiological diagnosis in 2020 beyond COVID-19? Cercenado, Emilia Rev Esp Quimioter Update in Infection Diseases 2020 The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications related to new diagnostic tests, methods for rapid antimicrobial susceptibility testing and for the detection of resistance genes, new diagnostic technologies, and some aspects related to old and emergent pathogens (Candida auris, Elizabethkingia spp. Streptococcus pyogenes) are summarized. Sociedad Española de Quimioterapia 2021-09-30 2021 /pmc/articles/PMC8683012/ /pubmed/34598413 http://dx.doi.org/10.37201/req/s01.01.2021 Text en © The Author 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Update in Infection Diseases 2020
Cercenado, Emilia
What happened to microbiological diagnosis in 2020 beyond COVID-19?
title What happened to microbiological diagnosis in 2020 beyond COVID-19?
title_full What happened to microbiological diagnosis in 2020 beyond COVID-19?
title_fullStr What happened to microbiological diagnosis in 2020 beyond COVID-19?
title_full_unstemmed What happened to microbiological diagnosis in 2020 beyond COVID-19?
title_short What happened to microbiological diagnosis in 2020 beyond COVID-19?
title_sort what happened to microbiological diagnosis in 2020 beyond covid-19?
topic Update in Infection Diseases 2020
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683012/
https://www.ncbi.nlm.nih.gov/pubmed/34598413
http://dx.doi.org/10.37201/req/s01.01.2021
work_keys_str_mv AT cercenadoemilia whathappenedtomicrobiologicaldiagnosisin2020beyondcovid19